TCM
ABMD

Timpani Capital Management’s Abiomed Inc ABMD Stock Holding History

Timpani Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,721
Closed -$1.88M – 122
2016
Q4 		$1.88M Sell
16,721
-12,214
-42% -$1.41M 0.78% 55
2016
Q3 		$3.72M Buy
28,935
+127
+0.4% +$15.2K 1.48% 27
2016
Q2 		$3.15M Buy
+28,808
New +$2.87M 1.33% 28

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Timpani Capital Management's ABMD Position: Q1 2017 in Review

Timpani Capital Management sold out of Abiomed Inc (ABMD) in Q1 2017, closing a stake of 16,721 shares — an estimated $1.88M sold.

Timpani Capital Management first reported a position in ABMD in Q2 2016 and held it in 3 quarters. The position peaked at $3.72M in Q3 2016. 287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

  • Timpani Capital Management reported no remaining Abiomed Inc position as of Q1 2017 after selling out during the quarter.
  • Timpani Capital Management sold 16,721 Abiomed Inc shares in Q1 2017, an estimated $1.88M.
  • Timpani Capital Management first reported a position in Abiomed Inc in Q2 2016 and held it in 3 quarters.
  • Timpani Capital Management's Abiomed Inc position peaked at $3.72M in Q3 2016.
  • 287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on Timpani Capital Management's 13F filing for Q1 2017, filed 12 May 2017.